• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

千里光菲灵碱是菊三七中的主要吡咯里西啶生物碱,通过激活线粒体介导的细胞凋亡诱导小鼠和原代肝细胞的肝毒性。

Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis.

机构信息

The MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

J Appl Toxicol. 2020 Nov;40(11):1534-1544. doi: 10.1002/jat.4004. Epub 2020 Jul 3.

DOI:10.1002/jat.4004
PMID:32618019
Abstract

Herbal drug-induced liver injury has been reported worldwide and gained global attention. Thousands of hepatic sinusoidal obstruction syndrome (HSOS) cases have been reported after consumption of herbal medicines and preparations containing pyrrolizidine alkaloids (PAs), which are natural phytotoxins globally distributed. And herbal medicines, such as Gynura japonica, are the current leading cause of PA-induced HSOS. The present study aimed to reveal the mechanism underlying the hepatotoxicity of seneciphylline (Seph), a main PA in G. japonica. Results showed that Seph induced severe liver injury through apoptosis in mice (70 mg/kg Seph, orally) and primary mouse and human hepatocytes (5-50 μM Seph). Further research uncovered that Seph induced apoptosis by disrupting mitochondrial homeostasis, inducing mitochondrial depolarization, mitochondrial membrane potential (MMP) loss, and cytochrome c (Cyt c) release and activating c-Jun N-terminal kinase (JNK). The Seph-induced apoptosis in hepatocytes could be alleviated by Mdivi-1 (50 μM, a dynamin-related protein 1 inhibitor), as well as SP600125 (25 μM, a specific JNK inhibitor) and ZVAD-fmk (50 μM, a general caspase inhibitor). Moreover, the Seph-induced MMP loss in hepatocytes was also rescued by Mdivi-1. In conclusion, Seph induced liver toxicity via activating mitochondrial-mediated apoptosis in mice and primary hepatocytes. Our results provide further information on Seph detoxification and herbal medicines containing Seph such as G. japonica.

摘要

草药药物性肝损伤已在全球范围内报道,并引起了全球关注。在消费含有吡咯里西啶生物碱(PAs)的草药和制剂后,已经报告了数千例肝窦阻塞综合征(HSOS)病例,PAs 是全球分布的天然植物毒素。而一些草药,如 Gynura japonica,是目前导致吡咯里西啶生物碱引起的 HSOS 的主要原因。本研究旨在揭示 Seneciphylline(Seph),G. japonica 中的主要 PAs,引起肝毒性的机制。结果表明,Seph 通过诱导小鼠(70mg/kg Seph,口服)和原代小鼠和人肝细胞(5-50μM Seph)中的细胞凋亡引起严重的肝损伤。进一步的研究揭示,Seph 通过破坏线粒体稳态、诱导线粒体去极化、线粒体膜电位(MMP)丧失、细胞色素 c(Cyt c)释放和激活 c-Jun N-末端激酶(JNK)来诱导细胞凋亡。Mdivi-1(50μM,一种与动力蛋白相关蛋白 1抑制剂)、SP600125(25μM,一种特异性 JNK 抑制剂)和 ZVAD-fmk(50μM,一种通用 caspase 抑制剂)可以减轻 Seph 诱导的肝细胞凋亡。此外,Mdivi-1 还可以挽救 Seph 诱导的肝细胞中 MMP 的丧失。总之,Seph 通过激活小鼠和原代肝细胞中线粒体介导的凋亡引起肝毒性。我们的研究结果为 Seph 解毒和含有 Seph 的草药,如 G. japonica,提供了进一步的信息。

相似文献

1
Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis.千里光菲灵碱是菊三七中的主要吡咯里西啶生物碱,通过激活线粒体介导的细胞凋亡诱导小鼠和原代肝细胞的肝毒性。
J Appl Toxicol. 2020 Nov;40(11):1534-1544. doi: 10.1002/jat.4004. Epub 2020 Jul 3.
2
Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice.抑制动力相关蛋白1(Drp1)可保护原代肝细胞和小鼠免受千里光宁碱诱导的线粒体介导的细胞凋亡。
Redox Biol. 2017 Aug;12:264-273. doi: 10.1016/j.redox.2017.02.020. Epub 2017 Mar 2.
3
Exposure to Gynura japonica (Thunb.) Juel plants induces hepatoxicity in rats and Buffalo rat liver cells.食用菊三七(Thunb.)Juel 植物会导致大鼠和布法罗大鼠肝细胞中毒。
J Ethnopharmacol. 2024 Dec 5;335:118692. doi: 10.1016/j.jep.2024.118692. Epub 2024 Aug 14.
4
Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism.吡咯里西啶生物碱化合物中间体的肝毒性:与其他吡咯里西啶生物碱的比较及其毒理学机制。
Toxins (Basel). 2021 Nov 28;13(12):849. doi: 10.3390/toxins13120849.
5
The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.体内吡咯里西啶生物碱衍生的吡咯蛋白加合物的长期持久性:含有菊三七提取物的吡咯里西啶生物碱多次暴露后的动力学研究。
Toxicol Lett. 2020 May 1;323:41-47. doi: 10.1016/j.toxlet.2020.01.021. Epub 2020 Jan 23.
6
Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.莪术根茎含吡咯里西啶生物碱,通过上调纤维化相关因子诱导小鼠肝窦阻塞综合征。
Acta Pharmacol Sin. 2019 Jun;40(6):781-789. doi: 10.1038/s41401-018-0155-y. Epub 2018 Oct 26.
7
Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes.N-乙酰间氨基酚(AMAP)诱导原代人肝细胞发生肝毒性过程中,线粒体蛋白加合物的形成及线粒体功能障碍。
Toxicol Appl Pharmacol. 2015 Dec 1;289(2):213-22. doi: 10.1016/j.taap.2015.09.022. Epub 2015 Sep 30.
8
Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.比较分析菊三七不同药用部位的有毒成分及其对小鼠的毒性评估。
Phytomedicine. 2019 Feb 15;54:77-88. doi: 10.1016/j.phymed.2018.06.015. Epub 2018 Jul 2.
9
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
10
Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.吡咯里西啶生物碱诱导的肝毒性与活性代谢物衍生的吡咯蛋白加合物的形成有关。
Toxins (Basel). 2021 Oct 13;13(10):723. doi: 10.3390/toxins13100723.

引用本文的文献

1
Novel photodynamic therapy using two-dimensional NiPS nanosheets that target hypoxic microenvironments for precise cancer treatment.利用二维NiPS纳米片靶向缺氧微环境进行精确癌症治疗的新型光动力疗法。
Nanophotonics. 2022 Dec 1;12(1):81-98. doi: 10.1515/nanoph-2022-0520. eCollection 2023 Jan.
2
Gut microbiota promotes macrophage M1 polarization in hepatic sinusoidal obstruction syndrome via regulating intestinal barrier function mediated by butyrate.肠道微生物群通过调控丁酸介导的肠道屏障功能促进肝窦阻塞综合征中巨噬细胞 M1 极化。
Gut Microbes. 2024 Jan-Dec;16(1):2377567. doi: 10.1080/19490976.2024.2377567. Epub 2024 Jul 16.
3
Hyperoside attenuates pyrrolizidine alkaloids-induced liver injury by ameliorating TFEB-mediated mitochondrial dysfunction.
金丝桃苷通过改善TFEB介导的线粒体功能障碍减轻吡咯里西啶生物碱诱导的肝损伤。
Arch Pharm Res. 2023 Aug;46(8):694-712. doi: 10.1007/s12272-023-01460-3. Epub 2023 Sep 21.
4
Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.双环醇对葛花诱导的肝窦阻塞综合征的影响。
J Clin Lab Anal. 2022 Dec;36(12):e24793. doi: 10.1002/jcla.24793. Epub 2022 Nov 29.
5
Combined Hepatotoxicity and Toxicity Mechanism of Intermedine and Lycopsamine.英地那韦和藜芦碱的联合肝毒性及其毒性机制。
Toxins (Basel). 2022 Sep 13;14(9):633. doi: 10.3390/toxins14090633.
6
Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.绞股蓝通过损害自噬诱导小鼠肝窦阻塞综合征。
Acta Cir Bras. 2022 Feb 18;36(11):e361104. doi: 10.1590/ACB361104. eCollection 2022.
7
Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid.血小板压积预测吡咯里西啶生物碱所致肝窦阻塞综合征患者预后的价值。
J Clin Lab Anal. 2022 Feb;36(2):e24240. doi: 10.1002/jcla.24240. Epub 2022 Jan 16.
8
Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism.吡咯里西啶生物碱化合物中间体的肝毒性:与其他吡咯里西啶生物碱的比较及其毒理学机制。
Toxins (Basel). 2021 Nov 28;13(12):849. doi: 10.3390/toxins13120849.
9
Toxic Prediction of Pyrrolizidine Alkaloids and Structure-Dependent Induction of Apoptosis in HepaRG Cells.吡咯里西啶生物碱的毒性预测及 HepaRG 细胞中结构依赖性细胞凋亡的诱导。
Oxid Med Cell Longev. 2021 Jan 2;2021:8822304. doi: 10.1155/2021/8822304. eCollection 2021.